P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma

Autor: Guo, R., Preeshagul, I., Schoenfeld, A., Mccarthy, C., Makhnin, A., Plodkowski, A., Ginsberg, M., Davare, M., Delasos, L., Somwar, R., Arcila, M., Riely, G., Rekhtman, N., Ladanyi, M., Kris, M., Drilon, A.
Zdroj: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S574-S575
Databáze: ScienceDirect